These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3525396)

  • 1. Quantitative correlation between molar refractivity and the inhibition of dihydrofolate reductase by 2,4-diamino-5-benzylpyrimidines.
    Kumar NA; Rao MN
    Indian J Biochem Biophys; 1986 Feb; 23(1):58-60. PubMed ID: 3525396
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
    Li RL; Poe M
    J Med Chem; 1988 Feb; 31(2):366-70. PubMed ID: 3276891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines.
    Hirst JD
    J Med Chem; 1996 Aug; 39(18):3526-32. PubMed ID: 8784450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The synthesis of the dihydrofolate reductase inhibitors 2,4-diamino-5-substituted-benzylpyrimidines and their inhibition on L. casei DHFR and chicken liver DHFR].
    Fang ZX; Li RL; Jiang YM; Gao JN
    Yao Xue Xue Bao; 1988 Feb; 23(2):108-14. PubMed ID: 3188916
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the selectivity of the dihydrofolate reductase inhibitor 5-substituted benzyl-2,4-diamino-pyrimidines].
    Li RL; Fang ZX
    Yao Xue Xue Bao; 1986 Oct; 21(10):753-60. PubMed ID: 3577775
    [No Abstract]   [Full Text] [Related]  

  • 9. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 11. Quinolylmethyl analogues with basic substituents conveying specificity.
    Davis SE; Rauckman BS; Chan JH; Roth B
    J Med Chem; 1989 Aug; 32(8):1936-42. PubMed ID: 2502633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
    Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 10. 2,4-Diamino-5-(6-quinolylmethyl)- and -[(tetrahydro-6-quinolyl)methyl]pyrimidine derivatives. Further specificity studies.
    Rauckman BS; Tidwell MY; Johnson JV; Roth B
    J Med Chem; 1989 Aug; 32(8):1927-35. PubMed ID: 2502632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase.
    Johnson JV; Rauchman BS; Baccanari DP; Roth B
    J Med Chem; 1989 Aug; 32(8):1942-9. PubMed ID: 2666668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.
    Hopfinger AJ
    J Med Chem; 1983 Jul; 26(7):990-6. PubMed ID: 6345782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate inhibitors: a structure-activity analysis using linear modeling.
    Hansch C
    Ann N Y Acad Sci; 1971 Nov; 186():235-47. PubMed ID: 4943575
    [No Abstract]   [Full Text] [Related]  

  • 17. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Dietrich SW; Blaney JM; Reynolds MA; Jow PY; Hansch C
    J Med Chem; 1980 Nov; 23(11):1205-12. PubMed ID: 7005446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Li RL; Dietrich SW; Hansch C
    J Med Chem; 1981 May; 24(5):538-44. PubMed ID: 7017146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.